celltech group independent biotechnology company halved pretax losses intends seek listing shares 1994 a loss pounds 658m pounds 125m incurred year september 30 turnover pounds 17m pounds 199m the company completed restructuring programme research focused projects aimed large markets cancer therapy transplant technology